BMC COMPLEMENT MED 润色咨询

BMC Complementary Medicine and Therapies

出版年份:2020 年文章数:734 投稿命中率: 开通期刊会员,数据随心看

出版周期:C 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2024-04-06 ms9000001026547573 来自香港

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:补充医学;临床
    经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。
    第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。
    觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2021-11-03 ms3000000150745947

    好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2023-11-06 147350dfm22暂无昵称 来自广东省

    偏重的研究方向:药学
    经验分享:10月16号提交技术审查,到现在都还没通过。。。。

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2023-11-20 ms5000001496653792 来自天津

    审稿速度:2.0
    经验分享:发

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2023-08-16 ms8000001033052510 来自湖南省

    有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2023-08-16 ms8000001033052510 来自湖南省

    Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2023-07-21 ms4000000353566827 来自重庆

    这个杂志太慢了,技术审查都要半个多月

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2021-06-15 12171fa9m59暂无昵称

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:干细胞;中药小分子
    经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF
    拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2023-07-21 ms4000000353566827 来自重庆

    太慢了,这个早在,技术审查都要2周多!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2149122, encodeId=d60221491226a, content=这个杂志太慢了,技术审查都要半个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:07:47 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149121, encodeId=bead214912135, content=太慢了,这个早在,技术审查都要2周多!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2325682687, createdName=ms4000000353566827, createdTime=Fri Jul 21 10:06:08 CST 2023, time=2023-07-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2146876, encodeId=d4a121468e631, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:中医药;肿瘤<br>经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf546397231, createdName=ms3000000405598630, createdTime=Fri Jul 07 22:57:37 CST 2023, time=2023-07-07, status=1, ipAttribution=北京)]
    2023-07-07 ms3000000405598630 来自北京

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:中医药;肿瘤
    经验分享:2月初投稿,5月22号收到返修意见,三个审稿人,2个小修,1个大修,2周返回,6月30号收到二次返修(修改了一条参考文献),现在7月7日又开始邀请三个审稿人,铁子们,这是啥意思啊?好煎熬啊

    2

    展开2条回复
共50条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分